Journal
CLINICAL NUCLEAR MEDICINE
Volume 40, Issue 3, Pages 258-259Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000606
Keywords
FDG; PET/CT; ipilimumab; melanoma; hepatitis